Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psoriasis
•
Dermatology
•
Primary Care
•
Viral Hepatitis
Do you caution against starting biologics for psoriasis if patient has hepatitis A antibodies?
Answer from: at Academic Institution
No
Comments
at Jefferson Regional Medical Center
No
12435
Sign In
or
Register
to read more
23143
Related Questions
How would you manage active severe psoriasis in a patient planning pregnancy, who also has psoriatic arthritis with well-controlled joint symptoms on certolizumab pegol (anti-TNF therapy)?
What treatment options would you recommend for a patient with severe generalized pustular psoriasis who has a history of colon cancer (s/p chemotherapy) and well-controlled HIV?
What circumstances would drive you to consider using an oral IL-23 inhibitor over parenteral options for the management of psoriasis and/or psoriatic arthritis?
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
What is your approach to young teenagers with acne who have extremely sensitive skin, cannot tolerate typical acne regimens, cannot tolerate oral antibiotics, and refuse Accutane?
Would oral roflumilast be a reasonable and tolerable option for severe psoriasis in an elderly patient with a history of pulmonary aspergillosis who has failed other systemic therapies?
What is your approach to managing acne induced by psychiatric medications in patients who cannot discontinue the offending medication?
For patients on medications that are known to cause photosensitivity, would you counsel them to avoid laser hair removal or laser therapies?
What are the most effective treatments for flat warts on the face?
What patient factors do you feel are most important when considering reduced dosing regimens of IL17a inhibitors such as secukinumab and ixekizumab for psoriasis?
No